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Introduction

Imaging and Labs

• Diabetic ketoacidosis (DKA) is known to cause mild elevations in triglyceride
levels.

A

• Severe hypertriglyceridemia (HTG) is a well-known cause of acute pancreatitis
however, in unique cases, DKA has been shown to cause severe HTG leading
to the development of acute pancreatitis (AP).
• From the few cases in literature that have reported this triad of DKA, HTG,
and AP, even fewer have shown to be successfully treated with insulin therapy
alone with the severe degree of HTG that we discuss.

• The use of lipid-lowering agents, such as fibrates, can be used in most
conditions accompanied by HTG but not beneficial in patients with
lipoprotein lipase deficiency (5)
• Omega oils are essential fatty acid naturally present in fish, algae, and other
seafood; their use as a TG-lowering drug in the management of severe HTG is
recommended by both the National Lipid Association and the American Heart
Association (6)

Case Presentation

• Labs was significant for a blood glucose 370 mg/dL, high anion gap metabolic
acidosis (anion gap 21), lipase of 1095 U/L, triglyceride level of 16076 mg/dL,
cholesterol 1629 mg/dL and HbA1c of 11.2%.

Discussion

B

• She was diagnosed with AP and admitted to the ICU for treatment with
intravenous insulin infusion for the treatment of DKA and HTG with
aggressive IV fluids and electrolyte replacement.

• Previous studies have shown that an estimated mortality rate of up to 80%
can be seen in patients with AP and co-existing DKA (2).
• Therapeutic plasma exchange (TPE) or plasmapheresis is the modality of
choice for treating patients with pancreatitis due to severe HTG as it involves
the removal of plasma and substitutes it with a colloid solution such as
donated plasma or albumin.
• TPE is associated with increased cost, availability issues, and its mortality
benefits have not been completely established. In many cases, patients are
transferred to another institution for management.

• Patient’s DKA resolved and her triglyceride levels decreased from 16076 to
283 mg/dL over the next 5 days.

• IV insulin therapy is used until triglyceride levels are less than 500 mg/dL,
however its use in severely elevated HTG has not been well studied in the
literature. In our case, we were able to successfully and safely lower severely
elevated triglyceride levels without the need for plasmapheresis.

C

Conclusion
In our case, we have treated a triad of DKA, AP and severe HTG with a value of
16076 mg/dL with insulin therapy alone which has not been documented in our
literature search.

Pathophysiology
• DKA is known to cause mild elevations in triglyceride levels via insulin
deficiency however severe HTG (> 2000 mg/dL) is rare.
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ultrasound which showed AP and a confirmatory CT abdomen and pelvis
which showed severe AP of the distal body and tail of the pancreas.
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Figure 1. (A, B): Computed tomography images showing pancreatic inflammation
and edema (arrows) surrounding the head and tail of the pancreas
(C): The role of insulin deficiency in causing HTG leading to AP. Decreased
inhibition hormone-sensitive lipase leads to increased FFA which will be
converted to serum HTG causing AP. (3)
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